Attention à la dépression passagère /Références scientifiques

[1] B. Mc Mahon, S.B. Andersen, M.K. Madsen, L.V. Hjordt, I. Hageman, H. Dam, C. Svarer, S. Da Cunha­Bang, W.Barré, J. Madsen, L. Hasholt, V. Frokjaer, G.M. Knudsen. Patients with seasonal affective disorder show seasonal fluctuations in their cerebral serotonin transporter binding. Eur Neuropsychopharmacol. 2014;24(Suppl 2):S319
[2] A functional­dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5­hydroxytryptohan and fluvoxamine. Poeldinger W. et al., Psychopathology, 1991; 24: 53­81.

[3] Effect of 5­hydroxytryptophan on the sleep of normal human subjects. Wyatt RJ. et al.,Electro­encephalogr Clin Neurophysiol, 197;30: 501­5.

[4] 5­hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomised clinical trial. Titus F et al., Eur neurol. 1986; 25: 327­29.

[5] The effect of oral 5­hydroxytryptophan administration on feeding behaviour in obese adult female subjects. Ceci F. et al., J Neural Transm, 1989; 76: 109­117.
Eating behaviour and adherence to dietary prescriptions in obese adult subjects treated with 5­hydroxytryptophan. Cangiano C et al., Am J Clin nutr, 1992; 56: 863­7.
Effects of 5­hydroxytryptophan on eating behaviour and adherence to dietary prescriptions in obese adult subjects. Cangiano C. et al., Adv Exp Med Biol, 1991; 294: 591­593.
Effects of oral 5­hydroxytryptophan on energy intake and macronutrient selection in non­insulin dependant diabetic patients. Cangiano C et al., Int Obes relat Metab Disord. 1998;22: 648­654.

[6] Double­blind study of 5­hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. Caruso I. Et al., J int Med res. 1990; 18: 201­209.

[1] B. Mc Mahon, S.B. Andersen, M.K. Madsen, L.V. Hjordt, I. Hageman, H. Dam, C. Svarer, S. Da Cunha­Bang, W.Barré, J. Madsen, L. Hasholt, V. Frokjaer, G.M. Knudsen. Patients with seasonal affective disorder show seasonal fluctuations in their cerebral serotonin transporter binding. Eur Neuropsychopharmacol. 2014;24(Suppl 2):S319

[2] A functional­dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5­hydroxytryptohan and fluvoxamine. Poeldinger W. et al., Psychopathology, 1991; 24: 53­81.

[3] Effect of 5­hydroxytryptophan on the sleep of normal human subjects. Wyatt RJ. et al.,Electro­encephalogr Clin Neurophysiol, 197;30: 501­5.

[4] 5­hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomised clinical trial. Titus F et al., Eur neurol. 1986; 25: 327­29.

[5] The effect of oral 5­hydroxytryptophan administration on feeding behaviour in obese adult female subjects. Ceci F. et al., J Neural Transm, 1989; 76: 109­117.
Eating behaviour and adherence to dietary prescriptions in obese adult subjects treated with 5­hydroxytryptophan. Cangiano C et al., Am J Clin nutr, 1992; 56: 863­7.
Effects of 5­hydroxytryptophan on eating behaviour and adherence to dietary prescriptions in obese adult subjects. Cangiano C. et al., Adv Exp Med Biol, 1991; 294: 591­593.
Effects of oral 5­hydroxytryptophan on energy intake and macronutrient selection in non­insulin dependant diabetic patients. Cangiano C et al., Int Obes relat Metab Disord. 1998;22: 648­654.

[6] Double­blind study of 5­hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. Caruso I. Et al., J int Med res. 1990; 18: 201­209.

Laboratoire cellinnov.